FDA Clearance Tracker · P170039-S002
CustomFlex Artificial Iris
Last checked: Nov 20, 2026Latest source record: Oct 3, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Oct 3, 2019
Approved
Time to decision
441 days
Received Jul 19, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P170039-S002
- Device name
- CustomFlex Artificial Iris
- Applicant
- Humanoptics AG
- Applicant location
- Erlangen
- Received
- Jul 19, 2018
- Decided
- Oct 3, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P170039
Device type
- Device type
- Artificial iris (QBT)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval of the protocol for the post-approval study (PAS) protocol.
Source documents
Other decisions for Humanoptics AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CustomFlex Artificial IrisBreakthroughPMA
P170039 · Decided May 30, 2018 · 182 days after receipt
Device type: Artificial iris (QBT) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.